Skip to main content
Premium Trial:

Request an Annual Quote

NetGenics, Incyte Ink Deal to Link Software

Premium

CLEVELAND--NetGenics Inc. here has signed a deal with Incyte Pharmaceuticals to link the forthcoming Synergy software package to Incyte's database software in order to create a more comprehensive software product suite for the pharmaceutical desktop. Synergy, currently in beta, is a Java- and CORBA-based client-server software and services system that enhances researchers' ability to access and analyze data. Incyte is one of several investors in NetGenics.

Under terms of the deal, Incyte will incorporate certain aspects of NetGenics' software and CORBA framework into its database products, and work with NetGenics to develop an advanced product designed to provide increased functionality to its database and software subscribers. NetGenics will receive royalties on products developed through the partnership.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.